Comparison of MSCs and Muse cells: the possible use for healthspan optimization.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing cell mechanisms and literature without systematic methodology or primary trial data.
PubMed 40601066 · doi:10.1007/s10522-025-10275-2
What was done
The authors reviewed the biological characteristics, differentiation capacities, homing mechanisms, and immunological profiles of mesenchymal stem cells (MSCs) versus multilineage-differentiating stress enduring (Muse) cells, evaluating their comparative potential for healthspan optimization and tissue repair.
What was found
The abstract reports no numerical data or statistical comparisons. It describes qualitative functional differences: standard MSCs act mainly via paracrine and bystander mechanisms with limited tri-lineage differentiation and potential lung entrapment. In contrast, Muse cells sense sphingosine-1-phosphate damage signals, selectively home to injured tissues, clear apoptotic cells, and directly differentiate across lineages to reconstruct tissue architecture. The authors state that HLA-mismatched donor Muse cells survive long term in recipient tissues without immunosuppression.
Why it matters
This review highlights that purifying specific sub-populations like Muse cells from heterogeneous MSC preparations could substantially improve the targeted delivery and efficacy of regenerative anti-aging therapies.
Limits
The abstract contains no primary data, quantitative metrics, or sample sizes. Broad claims regarding clinical survival and therapeutic superiority are summarized from prior literature without systematic review methodology or risk-of-bias evaluation.
Cited by
- supports Multilineage-differentiating stress-enduring (Muse) cells have low immunogenicity and low tumorigenicity compared to other stem cells.